
| Salt Composition: | Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg) |
| Manufacturer: | Zunarsh Lifesciences Pvt Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Zunaglim MV 2mg/500mg/0.2mg Tablet is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels. Zunaglim MV 2mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Zunaglim MV 2mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines.
What is Zunaglim MV 2mg/500mg/0.2mg Tablet?
Zunaglim MV 2mg/500mg/0.2mg Tablet is a combination of three medications: Glimepiride, Metformin and Voglibose. This medication is used for the treatment of type 2 diabetes mellitus (DM). It helps improve blood glucose levels in adults when taken with proper diet and regular exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin works by lowering glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels. This combination is not indicated for the treatment of Type 1 DM.
What are possible side effects of Zunaglim MV 2mg/500mg/0.2mg Tablet?
Side effects associated with using Zunaglim MV 2mg/500mg/0.2mg Tablet include hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Are there specific conditions for which Zunaglim MV 2mg/500mg/0.2mg Tablet should not be taken?
Zunaglim MV 2mg/500mg/0.2mg Tablet should not be used in patients with known allergies to any component or excipient of this medication. Avoid use in patients with moderate to severe kidney disease and inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to take alcohol while taking Zunaglim MV 2mg/500mg/0.2mg Tablet?
No, combining Zunaglim MV 2mg/500mg/0.2mg Tablet with alcohol is not recommended. It can lower blood sugar levels (hypoglycemia) and potentially increase the risk of lactic acidosis.
Can Zunaglim MV 2mg/500mg/0.2mg Tablet cause hypoglycemia?
Yes, Zunaglim MV 2mg/500mg/0.2mg Tablet can contribute to hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely if you miss meals, drink alcohol, overdo exercise, or take other antidiabetic medicines concurrently.
What are the instructions for storing and disposing of Zunaglim MV 2mg/500mg/0.2mg Tablet?
Store this medication in its original packaging, tightly closed. Follow the instructions provided on the package or label for storage duration. Dispose of unused medicine properly. Ensure that it is not accessible to pets, children, or other individuals.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Zunaglim MV 2mg/500mg/0.2mg Tablet is to be taken empty stomach.
Alcohol
It is unsafe to consume alcohol with Zunaglim MV 2mg/500mg/0.2mg Tablet.
Breastfeed
Zunaglim MV 2mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Zunaglim MV 2mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.